EarlySense Gains Patent For Respiratory Trending Analysis Designed For Reducing “Never Events”
In March 2013, EarlySense Ltd. gained a US patent for the respiratory trending analysis portion of its EarlySense System, a touch-free monitoring system that detects a patient’s heart rate, respiration, and movement using a sensor placed under the bed mattress. The company is initially targeting the estimated two million medical surgical beds in US and European hospitals in hopes of improving patient safety and reducing preventable adverse events.
You may also be interested in...
Start-ups developing technologies to help hospitals avoid preventable medical errors known as “never events” are developing solutions to nosocomial infections, retained surgical objects, pressure ulcers, and medication errors.
Growth in the hemodynamic monitoring market is being fueled by several factors, including the aging population and the increasing demand for less invasive and noninvasive technologies for measuring global parameters of oxygen delivery. While barriers to entry are high in the hemodynamic monitoring business, the prospect for future growth is significant.
Having achieved a turnaround in its R&D and commercial fortunes, AstraZeneca’s hopes the opening of a new research center will herald its next wave of novel therapies.